Vergent Bioscience Appoints Adam Gridley as Chief Executive Officer
PRIVATEJun 09, 2026
Position
President
Company
Vergent Bioscience
Adam Gridley
MinneapolisBiotechnologyHealth CareTherapeutics
Description
Vergent Bioscience has announced the appointment of Adam Gridley as its President and Chief Executive Officer, succeeding John Santini, who transitions to Chief Technology Officer. This leadership change positions Vergent for its next growth phase toward commercialization and pipeline development.
Who to call at Vergent Bioscience, and when
A new leader at Vergent Bioscience brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Vergent Bioscience raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Vergent Bioscience, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Vergent Bioscience
Location
5810 W 78TH ST
Minneapolis, Minnesota, United States
About
Vergent Bioscience is a clinical-stage biotechnology company that is helping surgeons realize the full potential of minimally invasive and robotic-assisted surgery by significantly improving the visibility of tumors.
Vergent’s lead compound, VGT-309, is a tumor-targeted fluorescent imaging agent intentionally designed to enable surgeons to see previously undetected or difficult-to-find tumors during surgery in real-time, ensuring all tumor tissue is removed. We are first evaluating VGT-309 in lung cancer, with the potential to expand its application to a wide range of solid tumors.
Our approach directly addresses the clinical need and market opportunity for advanced visualization in open, laparoscopic, and robotic-assisted surgical procedures.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vergent Bioscience changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
MinneapolisBiotechnologyHealth CareTherapeutics